BioNTech SE (BVMF:B1NT34)
Brazil flag Brazil · Delayed Price · Currency is BRL
33.49
-2.51 (-6.97%)
At close: Aug 28, 2026

BioNTech SE Revenue

BioNTech SE had revenue of 145.80M EUR in the quarter ending June 30, 2026, a decrease of -56.99%. This brings the company's revenue in the last twelve months to 2.43B, down -15.71% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.

Revenue (ttm)
2.43B EUR
Revenue Growth
-15.71%
P/S Ratio
8.51
Revenue / Employee
310.79K EUR
Employees
7,807
Market Cap
133.55B BRL

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.05B162.80M5.63%
Dec 31, 20242.89B-1.03B-26.31%
Dec 31, 20233.92B-13.39B-77.33%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020482.30M373.70M344.11%
Dec 31, 2019108.60M-18.98M-14.87%
Dec 31, 2018127.58M65.98M107.11%
Dec 31, 201761.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.